Search results
Virginia Tech's Fralin Biomedical Research Institute at VTC makes transformative scientific advances to address human and animal health and disease.
- About Us
Founded in 2010, the Fralin Biomedical Research Institute at...
- About Us
Founded in 2010, the Fralin Biomedical Research Institute at VTC is one of the nation’s fastest-growing academic biomedical research enterprises and a destination for world-class researchers. The institute’s Virginia Tech scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain ...
In 2019, the research institute was renamed to Fralin Biomedical Research Institute at VTC. Unique Public-Private Partnership.
The $90-million, 139,000-square-foot expansion enables the institute to double its workforce by 2027. During the ceremony, Virginia Tech’s President Tim Sands underscored the importance of biomedical research – especially now, in the wake of a global pandemic.
Research conducted at the Fralin Biomedical Research Institute creates a bridge between basic science research at Virginia Tech and clinical expertise at Carilion Clinic and increases translational research opportunities for both partners.
To train the next generation of biomedical scientists and to advance transformative research, Virginia Tech and Carilion Clinic once again looked to AECOM to provide the design excellence required to expand their biomedical research capabilities.
People also ask
Who opened Fralin Biomedical Research Institute?
Why did Virginia Tech and Carilion Clinic choose AECOM?
Will Virginia Tech double its workforce by 2027?
What do Virginia Tech Scientists do?
Virginia Tech leaders, key partners, and government officials will formally open the $90-million, 139,000-square-foot Fralin Biomedical Research Institute at VTC addition at 4 Riverside Circle in Roanoke on Tuesday, Oct. 12.
